FrancophonIA/ELRC3.0 huggingface dataset:
English: By inhibiting the binding of substance P within the emetic centre, maropitant is effective against neural and humoral (central and peripheral) causes of vomiting.
Danish: Ved at hæmme bindingen af stof P i det emetiske center er maropitant effektivt mod neurale og humorale (centrale og perifere) årsager til opkastning.
English: A variety of in vitro assays have demonstrated that maropitant binds selectively at the NK1 receptor with dose-dependent functional antagonism of substance P activity.
Danish: En række forskellige in vitro-prøver har vist, at maropitant bindes selektivt til NK1-receptoren med dosisafhængig funktionel antagonisme til aktiviteten af stof P.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals, including isolated reports treated).
Danish: Hyppigheden af bivirkninger er defineret som: - Meget almindelige (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger) - Almindelige (flere end 1, men færre end 10 dyr ud af 100 behandlede dyr) - Ikke almindelige (flere end 1, men færre end 10 dyr ud af 1 000 behandlede dyr) - Sjældne (flere end 1, men færre end 10 dyr ud af 10 000 behandlede dyr) - Meget sjældne (færre end 1 dyr ud af 10 000 behandlede dyr, herunder isolerede rapporter).
English: Betadex sulfobutyl ether sodium Benzyl alcohol (E1519) Citric acid, anhydrous Sodium hydroxide Water for injections
Danish: Betadexsulfobutylethernatrium Benzylalkohol (E1519) Citronsyre, vandfri Natriumhydroxid Vand til injektionsvæsker
English: During clinical studies maropitant plasma levels conferred efficacy from 1 hour after administration.
Danish: I de kliniske undersøgelser medførte plasmakoncentrationen af maropitant virkning fra 1 time efter indgivelse.
English: As the pharmacokinetic variation is large and maropitant accumulates in the body after once daily repeated administration, lower doses than recommended might be sufficient in some individuals and when repeating the dose.
Danish: Da der er stor variation i stoffets omsætning, og da maropitant ophobes i kroppen ved gentagen indgivelse af én dosis dagligt, kan det være tilstrækkeligt med lavere doser end de anbefalede hos visse dyr, og når doseringen gentages.
English: Maropitant undergoes cytochrome P450 (CYP) metabolism in the liver.
Danish: Maropitant metaboliseres af cytokrom P450 (CYP) i leveren.
English: Pack sizes of 1 vial of 10 ml, 20 ml, 25 ml or 50 ml.
Danish: Pakningsstørrelser: ét hætteglas på 10 ml, 20 ml, 25 ml eller 50 ml.
English: As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function and any adverse events should be implemented during long term treatment.
Danish: Da maropitant ophobes i kroppen i løbet af en 14-dages behandlingsperiode som følge af metabolisk mætning, bør leverfunktionen og eventuelle bivirkninger nøje overvåges under den første langtidsbehandling.
English: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products in the same syringe.
Danish: Da der ikke foreligger undersøgelser vedrørende eventuelle uforligeligheder, må dette veterinærlægemiddel ikke blandes med andre veterinærlægemidler i samme sprøjte.
English: Plasma protein binding of maropitant in dogs is more than 99%.
Danish: Plasmaproteinbindingen af maropitant hos hunde er over 99 %.
English: The anti-emetic efficacy of maropitant against central and peripheral emetics was demonstrated in experimental studies including apomorphine, cisplatin and syrup of ipecac (dogs) and xylazine (cats).
Danish: Den antiemetiske virkning af maropitant mod central og perifer emesis blev påvist i eksperimentelle undersøgelser med brug af apomorfin, cisplatin, ipecacsirup (hunde) og xylazin (katte).
English: CYP1A and CYP3A-related enzymes were identified as the feline isoforms involved in the hepatic biotransformation of maropitant.
Danish: CYP1A- og CYP3A-relaterede enzymer er identificeret som de feline isoformer, der medvirker ved den hepatiske biotransformation af maropitant.
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Danish: Overdosering (symptomer, nødforanstaltninger, modgift om nødvendigt)
English: CYP2D15 and CYP3A12 were identified as the canine isoforms involved in the hepatic biotransformation of maropitant.
Danish: CYP2D15 og CYP3A12 blev identificeret som de hunde-isoformer, der medvirker ved den hepatiske biotransformation af maropitant.
English: For administration by subcutaneous injection, see also “special precautions for use in animals” (section 4.5).
Danish: Vedrørende subkutan injektion henvises desuden til "Særlige forsigtighedsregler vedrørende brug til dyr" (pkt.
English: Amber glass type I vial closed with a coated bromobutyl rubber stopper and aluminium cap in a cardboard box.
Danish: Ravfarvet hætteglas type I lukket med en bromobutylgummiovertrukken prop med aluminiumkapsel i en papæske.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label of the vial after EXP.
Danish: Brug ikke dette veterinærlægemiddel efter den udløbsdato, der står på hætteglasetiketten efter EXP. Udløbsdatoen refererer til den sidste dag i den nævnte måned.
English: • For the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the μ-opiate receptor agonist morphine.
Danish: • Forebyggelse af kvalme og opkastning i forbindelse med operationer samt bedre opvågnen efter helbedøvelse efter brug af morfin, der er en μ-opioid-receptoragonist.
English: • For the treatment and prevention of nausea induced by chemotherapy.
Danish: • Behandling og forebyggelse af kvalme forårsaget af kemoterapi.
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer responsible for batch release Produlab Pharma B.V.
Danish: FREMSTILLER ANSVARLIG FOR BATCHFRIGIVELSE Navn og adresse på fremstilleren ansvarlig for batchfrigivelse Produlab Pharma B.V.
English: Pain at injection site may occur when injected subcutaneously.
Danish: Smerter på injektionsstedet kan optræde ved subkutan injektion.
English: The veterinary medicinal product should be used with caution in animals suffering from or with predisposition for cardiac diseases as maropitant has affinity to Ca- and K-ion channels.
Danish: Der bør udvises forsigtighed ved anvendelse af veterinærlægemidlet hos dyr, der lider af eller er disponeret for hjertesygdomme, da maropitant har affinitet til Ca- and K-ionkanalerne.
English: Use only according to the benefit-risk assessment by the responsible veterinarian.
Danish: Må kun anvendes i overensstemmelse med den ansvarlige dyrlæges vurdering af benefit/risk-forholdet.
English: STATEMENT OF ACTIVE SUBSTANCES 10 mg/ml maropitant
Danish: ANGIVELSE AF AKTIVE STOFFER 10 mg/ml maropitant
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) 10 mg/ml
Danish: MÆNGDEN AF AKTIVT STOF (AKTIVE STOFFER) 10 mg/ml
English: In very rare cases, anaphylactic type reactions (allergic oedema, urticaria, erythema, collapse, dyspnoea, pale mucous membranes) may occur.
Danish: I meget sjældne tilfælde kan der forekomme anafylaktoide reaktioner (allergisk ødem, urticaria, erytem, kollaps, dyspnø, blege slimhinder).
English: The bioavailability of maropitant after subcutaneous administration in dogs was 90.7%.
Danish: Biotilgængeligheden af maropitant efter subkutan indgivelse hos hunde var 90,7 %.
English: Products such as Prevomax should be used in conjunction with other supportive measures such as dietary control and fluid replacement therapy, as recommended by your veterinary surgeon.
Danish: Produkter som Prevomax bør anvendes i forbindelse med andre støtteforanstaltninger såsom diæt og væskeerstatning som anbefalet af dyrlægen.
English: Plasma protein binding of maropitant in cats was estimated to be 99.1%.
Danish: Plasmaproteinbindingen af maropitant hos katte blev beregnet til 99,1 %.
English: Renal clearance is a minor route of elimination, with less than 1% of a 1 mg/kg subcutaneous dose appearing in the urine as either maropitant or its major metabolite.
Danish: Renal udskillelse er en mindre betydningsfuld eliminationsvej, idet mindre end 1 % af en dosis på 1 mg/kg subkutant genfindes i urinen som enten maropitant eller dets hovedmetabolit.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Glass vial
Danish: MINDSTEKRAV TIL OPLYSNINGER PÅ SMÅ INDRE PAKNINGER Hætteglas (glas)
English: Prevomax must not be mixed with other veterinary medicinal products in the same syringe as its compatibility with other products has not been tested.
Danish: Prevomax må ikke blandes med andre veterinærlægemidler i samme sprøjte, da der ikke er udført forligelighedsundersøgelser med andre produkter.
English: Maropitant is highly bound to plasma proteins and may compete with other highly bound medicines.
Danish: Maropitant er stærkt bundet til plasmaproteiner og kan være kompetitivt i forhold til andre stærkt bundne lægemidler.
English: Peak concentrations were followed by a decline in systemic exposure with an apparent elimination half-life (t1/2) of 8.84 hours.
Danish: Maksimalkoncentrationerne efterfulgtes af et fald i den systemiske eksponering med en tilsyneladende eliminationshalveringstid (t1/2) på 8,84 timer.
English: In the case of accidental eye exposure, flush the eyes with plenty of water and seek medical attention.
Danish: Ved utilsigtet kontakt med øjnene skal øjnene skylles med rigeligt vand, og der skal søges lægehjælp.
English: METHOD AND ROUTE(S) OF ADMINISTRATION SC, IV
Danish: ANVENDELSESMÅDE OG INDGIVELSESVEJ(E) SC, IV
English: Peak concentrations were followed by a decline in systemic exposure with an apparent elimination half-life (t1/2) of 16.8 hours.
Danish: Maksimalkoncentrationerne efterfulgtes af et fald i den systemiske eksponering med en tilsyneladende eliminationshalveringstid (t1/2) på 16,8 timer.
English: Maropitant is metabolised in the liver and therefore should be used with caution in dogs and cats with liver disease.
Danish: Maropitant omsættes i leveren, hvorfor der bør udvises forsigtighed hos hunde og katte med leversygdom.
English: Shelf life after first opening the immediate packaging: 56 days.
Danish: Opbevaringstid efter første åbning af den indre emballage: 56 dage.
English: Apart from transient reactions at the injection site following subcutaneous administration, maropitant was well tolerated in dogs and young cats injected daily with up to 5 mg/kg (5 times the recommended dose) for 15 consecutive days (3-times the recommended duration of administration).
Danish: Bortset fra forbigående reaktioner på injektionsstedet efter subkutan injektion er maropitant veltolereret hos hunde og unge katte ved daglig injektion af op til 5 mg/kg (fem gange den anbefalede dosis) i 15 på hinanden følgende dage (tre gange den anbefalede behandlingsvarighed).
English: Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.
Danish: Opkastning kan være forbundet med alvorlige, stærkt svækkende tilstande, herunder gastrointestinal obstruktion.
English: ROUTE(S) OF ADMINISTRATION SC, IV
Danish: INDGIVELSESVEJ(E) SC, IV
English: PHARMACEUTICAL FORM Solution for injection A clear, colourless to light yellow solution
Danish: LÆGEMIDDELFORM Injektionsvæske, opløsning Klar, farveløs til gullig væske
English: The efficacy of maropitant in reduction of nausea was demonstrated in studies using a model (xylazine-induced nausea).
Danish: Virkningen af maropitant til reduktion af kvalme er påvist i undersøgelser med anvendelse af en model (xylazin-induceret kvalme).
English: • For the treatment of vomiting, in combination with other supportive measures.
Danish: • I kombination med andre støtteforanstaltninger, behandling af opkastning.
English: To prevent vomiting, the veterinary medicinal product solution for injection should be administered more than 1 hour in advance.
Danish: Til forebyggelse af opkastning bør det veterinære lægemiddel, injektionsvæske, opløsning, gives mere end 1 time i forvejen.
English: Shelf life after first opening the vial: 56 days.
Danish: Holdbarhed efter første åbning af hætteglasset: 56 dage.
English: Therefore, it is recommended to administer the veterinary medicinal product prior to administration of the chemotherapeutic agent.
Danish: Det anbefales derfor, at veterinærlægemidlet indgives, inden der gives kemoterapi.
English: The elimination t1/2 following intravenous dosing was approximately 5.8 h.
Danish: Eliminationshalveringstiden efter intravenøs dosering var ca. 5,8 timer.
English: Following a single intravenous dose at 1 mg/kg the initial plasma concentration was 363 ng/ml.
Danish: Efter en enkelt intravenøs dosis på 1 mg/kg var den initiale plasmakoncentration 363 ng/ml.
English: Use only according to the benefit-risk assessment by the responsible veterinarian, because conclusive reproductive toxicity studies have not been conducted in any animal species.
Danish: Må kun anvendes i overensstemmelse med den ansvarlige dyrlæges vurdering af benefit/riskforholdet, da der ikke er udført undersøgelser af reproduktionstoksicitet i nogen dyreart.
English: TARGET SPECIES Dogs, cats
Danish: DYREARTER Hunde, katte
English: The veterinary medicinal product should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.
Danish: Veterinærlægemidlet bør ikke anvendes sammen med calciumkanalantagonister, da maropitant bindes til calciumkanaler.
English: To prevent vomiting, Prevomax solution for injection should be administered more than 1 hour in advance.
Danish: Til forebyggelse af opkastning bør Prevomax, injektionsvæske, opløsning, gives mere end 1 time i forvejen.
English: The safety of maropitant has not been established in dogs less than 8 weeks of age, or in cats less than 16 weeks of age, and in pregnant or lactating dogs and cats.
Danish: Sikkerheden af maropitant er ikke fastlagt hos hunde under 8 uger, hos katte under 16 uger og hos drægtige eller diegivende hunde og katte.
English: Intravenous administration of the veterinary medicinal product should be given as a single bolus without mixing the product with any other fluids.
Danish: Intravenøs indgivelse af det veterinære lægemiddel gives som en enkelt bolus, uden at produktet blandes med andre væsker.
English: People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.
Danish: Særlige forsigtighedsregler for personer, som indgiver lægemidlet til dyr Personer med kendt overfølsomhed over for maropitant bør administrere veterinærlægemidlet med forsigtighed.
English: The bioavailability of maropitant after subcutaneous administration in cats was 91.3%.
Danish: Biotilgængeligheden af maropitant efter subkutan indgivelse hos katte var 91,3 %.
English: Renal and faecal clearances are minor routes of elimination for maropitant, with less than 1% of a 1 mg/kg subcutaneous dose appearing in the urine or faeces as maropitant.
Danish: Den renale og fækale udskillelse er en mindre vigtig eliminationsvej for maropitant, idet mindre end 1 % af en subkutan dosis på 1 mg/kg genfindes i urin eller fæces som maropitant.
English: Following repeated subcutaneous administration of once-daily doses of 1 mg/kg bodyweight for five consecutive days, accumulation was 146%.
Danish: Efter gentagen subkutan indgivelse af enkeltdoser på 1 mg/kg kropsvægt dagligt i fem på hinanden følgende dage var akkumuleringen 146 %.
English: The responsible veterinarian should make a benefit-risk assessment before using the veterinary medicinal product in dogs less than 8 weeks of age, or in cats less than 16 weeks of age, or in pregnant or lactating bitches and cats.
Danish: Den ansvarlige dyrlæge bør foretage en vurdering af fordele og risici (benefit/risk-vurdering), inden dette veterinærlægemiddel anvendes hos hunde under 8 uger, katte under 16 uger eller drægtige eller diegivende tæver og katte.
English: Following a single intravenous dose at 1 mg/kg the initial plasma concentration was 1040 ng/ml.
Danish: Efter en enkelt intravenøs dosis på 1 mg/kg var den initiale plasmakoncentration 1 040 ng/ml.
English: Following repeated subcutaneous administration of once-daily doses of 1 mg/kg bodyweight for five consecutive days, accumulation was 250%.
Danish: Efter gentagen subkutan indgivelse af enkeltdoser på 1 mg/kg kropsvægt dagligt i fem på hinanden følgende dage var akkumuleringen 250 %.
English: The volume of distribution at steady-state (Vss) was 2.3 l/kg and systemic clearance was 0.51 l/h/kg.
Danish: Fordelingsvolumenet under standardbetingelser (Vss) var 2,3 l/kg, og den systemiske udskillelse var 0,51 l/h/kg.
English: Maropitant is metabolised in the liver and therefore should be used with caution in patients with hepatic disease.
Danish: Maropitant metaboliseres i leveren, hvorfor der bør udvises forsigtighed hos dyr med leversygdom.
English: • For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
Danish: • Forebyggelse af opkastning og reduktion af kvalme undtagen tilfælde, der skyldes køresyge.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains:
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING 1 ml indeholder: Aktivt stof: Maropitant
English: The efficacy of maropitant in reduction of nausea in cats was demonstrated in studies using a model (xylazine-induced nausea).
Danish: Virkningen af Maropitant til reduktion af kvalme hos katte er påvist i modelundersøgelser (xylazinfremkaldt kvalme).
English: Increases of approximately 10% in the QT interval of the ECG were observed in a study on healthy Beagle dogs administered 8 mg/kg orally; however, such an increase is unlikely to be of clinical significance.
Danish: Der er iagttaget en forøgelse af QT-intervallet på ca. 10 % i EKG i en undersøgelse på raske beaglehunde ved oral indgivelse af 8 mg/kg.
English: 11.1 mg For the full list of excipients, see section 6.1.
Danish: 11,1 mg Alle hjælpestoffer er anført under pkt.
English: The volume of distribution at steady-state (Vss) was 9.3 l/kg and systemic clearance was 1.5 l/h/kg.
Danish: Fordelingsvolumenet under standardbetingelser (Vss) var 9,3 l/kg, og den systemiske udskillelse var 1,5 l/h/kg.
English: The use of the veterinary medicinal product against vomiting due to motion sickness is not recommended.
Danish: Det frarådes at anvende veterinærlægemidlet mod opkastning forårsaget af køresyge.
English: Maropitant displays linear kinetics when administered subcutaneously within the 0.25-3 mg/kg dose range.
Danish: Maropitant udviser lineær kinetik ved subkutan indgivelse i dosisområdet 0,25-3 mg/kg.
English: Prevomax solution for injection should be injected subcutaneously or intravenously, once daily, at a dose of 1 mg of maropitant/kg body weight (1 ml/10 kg body weight).
Danish: Prevomax, injektionsvæske, opløsning, injiceres subkutant eller intravenøst én gang dagligt i en dosis på 1 mg maropitant/kg kropsvægt (1 ml/10 kg kropsvægt).
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) 1 ml contains:
Danish: ANGIVELSE AF DE(T) AKTIVE STOF(FER) OG ANDRE INDHOLDSSTOFFER 1 ml indeholder: Aktivt stof: Maropitant
English: The use of Prevomax solution for injection against vomiting due to motion sickness is not recommended.
Danish: Brug af Prevomax, injektionsvæske, opløsning, mod opkastning forårsaget af køresyge anbefales ikke.
English: Intravenous administration of Prevomax should be given as a single bolus without mixing the product with any other fluids.
Danish: Intravenøs indgivelse af Prevomax bør gives som en enkelt støddosis (bolus), uden at produktet blandes med andre væsker.
English: Maropitant displays linear kinetics when administered subcutaneously within the 0.5-2 mg/kg dose range.
Danish: Maropitant udviser lineær kinetik ved subkutan indgivelse i dosisområdet 0,5-2 mg/kg.
English: Signs of nausea in dogs including excessive salivation and lethargy might remain after treatment.
Danish: Efter behandlingen kan der hos hunde persistere tegn på kvalme, herunder stærkt spytflåd og letargi.
English: The veterinary medicinal product solution for injection should be injected subcutaneously or intravenously, once daily, at a dose of 1 mg of maropitant / kg bodyweight (1 ml/10 kg bodyweight) for up to 5 consecutive days.
Danish: Det veterinære lægemiddel, injektionsvæske, opløsning, injiceres subkutant eller intravenøst én gang dagligt i en dosis på 1 mg maropitant/kg kropsvægt (1 ml/10 kg kropsvægt) i op til 5 på hinanden følgende dage.
English: • For the prevention of vomiting except that induced by motion sickness.
Danish: • Forebyggelse af opkastning bortset fra opkastning, der skyldes køresyge.
English: EXP Once broached use within 56 days.
Danish: EXP Skal anvendes senest 56 dage efter åbning.
English: The pharmacokinetic profile of maropitant when administered as a single subcutaneous dose of 1 mg/kg body weight to dogs was characterised by a maximum concentration (Cmax) in plasma of approximately 92 ng/ml; this was achieved within 0.75 hours post-dosing (Tmax).
Danish: Den farmakokinetiske profil af maropitant ved indgivelse af en subkutan enkeltdosis på 1 mg/kg kropsvægt til hunde var karakteriseret af en maksimal plasmakoncentration (Cmax) på ca. 92 ng/ml.
English: Prevomax should be used with caution in animals suffering from or with predisposition for heart diseases.
Danish: Hos dyr med hjertesygdomme eller disposition for hjertesygdomme bør der udvises forsigtighed.
English: The pharmacokinetic profile of maropitant when administered as a single subcutaneous dose of 1 mg/kg body weight to cats was characterised by a maximum concentration (Cmax) in plasma of approximately 165 ng/ml; this was achieved on average 0.32 hours (19 min) post-dosing (Tmax).
Danish: Den farmakokinetiske profil af maropitant ved indgivelse af en enkelt subkutan dosis på 1 mg/kg kropsvægt til katte var karakteriseret af en maksimalkoncentration (Cmax) i plasma på ca. 165 ng/ml.
English: 4.2 Indications for use, specifying the target species
Danish: Terapeutiske indikationer, med angivelse af dyrearter, som lægemidlet er beregnet til
English: The elimination t1/2 following intravenous dosing was approximately 4.9 h. There appears to be an age-related effect on the pharmacokinetics of maropitant in cats with kittens having higher clearance than adults.
Danish: Der synes at være en aldersrelateret sammenhæng med farmakokinetikken af maropitant hos katte, idet killinger har højere udskillelse end voksne katte.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Prevomax 10 mg/ml injection maropitant
Danish: VETERINÆRLÆGEMIDLETS NAVN Prevomax, 10 mg/ml, injektionsvæske
English: 5.2 Pharmacokinetic particulars
Danish: Farmakokinetiske oplysninger
English: Le Vet Beheer B.V. Wilgenweg 7
Danish: Le Vet Beheer B.V.
English: PACKAGE LEAFLET: Prevomax 10 mg/ml solution for injection for dogs and cats
Danish: INDLÆGSSEDDEL: Prevomax, 10 mg/ml, injektionsvæske, opløsning, til hunde og katte
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Prevomax 10 mg/ml solution for injection for dogs and cats Maropitant
Danish: VETERINÆRLÆGEMIDLETS NAVN Prevomax, 10 mg/ml, injektionsvæske, opløsning, til hunde og katte maropitant
English: EXPIRY DATE EXP {month/year} Once broached use within 56 days.
Danish: 10. UDLØBSDATO EXP {måneder/år}
English: Maropitant has been shown to be a potential eye irritant, and in the case of accidental eye exposure, flush the eyes with plenty of water and seek medical attention.
Danish: Ved utilsigtet kontakt med øjnene skylles øjnene med rigeligt vand, og der søges læge.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Prevomax 10 mg/ml solution for injection for dogs and cats
Danish: VETERINÆRLÆGEMIDLETS NAVN Prevomax, 10 mg/ml, injektionsvæske, opløsning, til hunde og katte